Corona Remedies Ltd share price logo

Corona Remedies Ltd

NSE: CORONA

BSE: 544644

Small Cap

Pharma Sector

₹2119.40

+6.30

(+0.30%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Corona Remedies Stock Performance

as on August 18, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹2,105.70
    ₹2,150.00
    downward going graph

    0.65%

    Downside

    1.44%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,336.60
    ₹2,270.10
    downward going graph

    36.93%

    Downside

    7.11%

    Upside

    downward going graph

Corona Remedies share price movements today

Previous Close
₹2,113.10
Open
₹2,129.00
Volume
16.60K
Upper Circuit
₹2,535.70
Lower Circuit
₹1,690.50
Day's Low - High
₹2,105.70 - ₹2,150.00
52 Week Low - High
₹1,336.60 - ₹2,270.10

Corona Remedies Historical Returns

1 Month Return
+ 3.27 %
3 Month Return
+ 16.09 %
1 Year Return
+ 46.91 %
3 Year Return
+ 46.91 %
5 Year Return
+ 46.91 %

Corona Remedies Fundamentals

as on August 18, 2026 at 4:01 pm IST

Market Cap

₹12,923.74 Cr

Return on Equity (ROE)

27.35

PE Ratio (TTM)

0

Return on capital employed (ROCE)

28.95

Industry PE ratio

-

Beta (LTM)

0.63

P/B Ratio

12.76

Dividend Yield

0.64

PEG Ratio

0

Quarterly Earnings Growth YOY

30.11

EPS (TTM)

30.27

Book Value

122.12

Corona Remedies Technical Analysis

Track how Corona Remedies technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish11
Bullish
Neutral4

Oscillators

Name

Value

Action

MACD level (12,26)
-0.75
Bearish
CCI (20)
89.45
Neutral
RSI (14)
40.5
Neutral
Momentum (10)
-7.9
Bearish
ADI (14)
21.78
Neutral
Ultimate Oscillator (7,14,28)
36.33
Neutral

Moving Averages

Name

Value

Action

SMA (20)
2120.07
Bearish
EMA (20)
2118.84
Bearish
VWMA (20)
2119.19
Bearish
SMA (50)
2119.29
Bearish
EMA (50)
2119.14
Bearish
SMA (200)
2118.35
Bearish
EMA (200)
2118.41
Bearish
KAMA (200)
2118.57
Bearish
DEMA (200)
2119.09
Bearish

Corona Remedies Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Corona Remedies with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Corona Remedies Ltd image
Corona Remedies Ltd
BUY12,923.749.38%0.621851,403
Pentokey Organy (India) Ltd image
Pentokey Organy (India) Ltd
NA22.0117.25%0.0034
Lincoln Pharmaceuticals Ltd image
Lincoln Pharmaceuticals Ltd
NA1,248.5517.19%0.5082623
Norris Medicines Ltd image
Norris Medicines Ltd
NA15.5811.96%0.00-25
Brooks Laboratories Ltd image
Brooks Laboratories Ltd
NA178.69-9.92%0.542485
See all

Market expectation of Corona Remedies Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Corona Remedies Stock’s Investor Sentiment and Interest

Search interest for Corona Remedies Ltd Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Corona Remedies Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
291.17
313.87
297.69
293.69
346.54
361.13
342.42
353.09
422.43
Other Income
1.29
2.46
0.94
1.63
2.02
2.44
2.26
4.39
3.16
Total Income
292.46
316.33
298.63
295.32
348.56
363.57
344.68
357.48
425.59
Expenses
241.65
247.06
228.27
239.47
276.96
282.66
278.36
291.07
329.3
Operating Profit
49.52
66.81
69.42
54.22
69.58
78.47
64.06
62.02
93.13
Operating Profit Margin %
17.01%
21.29%
23.32%
18.46%
20.08%
21.73%
18.71%
17.56%
22.05%
Profit Before Interest, Tax and Depreciation
50.81
69.27
70.36
55.85
71.6
80.91
66.32
66.41
96.29
Interest
3.15
2.87
2.39
2.2
1.99
1.93
1.66
1.38
2.69
Depreciation
8.38
9.05
9.69
10.04
8.92
9.2
9.45
10.29
13.24
Profit Before Tax
39.28
57.35
58.28
43.61
60.69
69.78
55.21
54.74
80.36
Tax Paid
9.33
14.38
13.33
12.06
14.49
17.46
13.94
9.41
20.25
Profit After Tax
29.95
42.97
44.95
31.55
46.2
52.32
41.27
45.33
60.11
Total Net profit including share of profit / Loss from associate company
29.95
42.97
44.95
31.55
46.2
52.32
41.27
45.33
60.11
EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
7.41
9.83
Actual EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
7.41
9.83
Adjusted EPS
4.9
7.03
7.35
5.16
7.55
8.55
6.75
7.41
9.83
Diluted EPS
-
7.03
7.35
5.16
7.55
8.55
6.75
7.41
9.83

Corona Remedies Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
884.05
1,014.47
1,196.42
1,403.18
Other Income
7.28
6.46
6.31
10.92
Total Income
891.33
1,020.94
1,202.73
1,414.1
Expenses
756.07
859.74
956.44
1,128.84
Operating Profit
127.98
154.73
239.98
274.34
Operating Profit Margin %
14.48%
15.25%
20.06%
19.55%
Profit Before Interest, Tax and Depreciation
135.26
161.2
246.29
285.26
Interest
4.27
14.44
10.6
6.97
Depreciation
20.1
28.28
37.16
37.87
Profit Before Tax
110.89
118.48
198.53
240.42
Tax Paid
25.96
27.98
49.1
55.3
Profit After Tax
84.93
90.5
149.43
185.12
Total Net profit including share of profit / Loss from associate company
84.93
90.5
149.43
185.12
EPS
14.57
14.8
24.43
30.27
Actual EPS
14.57
14.8
24.43
30.27
Adjusted EPS
14.57
14.8
24.43
30.27
Diluted EPS
14.57
14.8
24.43
30.27

Corona Remedies Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
102.7
156.76
190.49
229.48
Cash Flow from Investing Activities
-50.28
-266.64
-83.86
-256.15
Cash Flow from Financing Activities
-44.75
98.54
-106.57
25.28
Net Cash Flow
7.67
-11.34
0.06
-1.39

Corona Remedies Stock Shareholding Pattern

Numbers in percentages

Apr 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
72.5%
69%
69%
69%
DII
0%
6.76%
7.02%
12.9%
FII
0%
1.84%
2.25%
3.63%
Public
0%
22.4%
21.74%
14.48%
Total Outstanding Shares
6,11,60,088
6,11,60,088
6,11,60,088
6,11,60,088
Total Shareholders
9
31,035
19,609
20,185

Mutual Funds that own Corona Remedies Stock

Check out the Mutual Funds with significant holdings in Corona Remedies.

Corona Remedies Corporate Actions

View detailed summary of the earnings and dividend history of Corona Remedies.

  • Corona Remedies Ltd Earnings Results

    Corona Remedies Ltd’s net profit jumped 30.11% since last year same period to ₹60.11Cr in the Q1 2026-2027. On a quarterly growth basis, Corona Remedies Ltd has generated 32.61% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Corona Remedies Ltd Dividends May,2026

    In the quarter ending March 2026, Corona Remedies Ltd has declared dividend of ₹10.00 per share on 11 May 2026 - translating a dividend yield of 0.47%.

    Read More about Dividends

Indices Featuring Corona Remedies Stock

Check stock indices that include Corona Remedies.

BSE IPO

₹18,159.02

43.98 (▲0.24%)

BSE Healthcare

₹50,813.83

124.45 (▲0.25%)

Insights on Corona Remedies Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 6.35% to 12.50% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.25% to 3.63% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, CORONA stock has moved up by 33.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 69.00% of holdings in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.74% to 14.48% in Jun 2026 quarter

About Corona Remedies Ltd

Corona Remedies Limited was originally incorporated as CORONA Remedies Private Limited a private limited company dated August 27 2004 issued by the Assistant Registrar of Companies Gujarat at Dadra and Nagar Haveli. Thereafter Company converted into a public limited and Company name has changed to CORONA Remedies Limited. A fresh certificate of incorporation is issued by the Registrar of Companies Central Processing Centre Manesar Haryana on December 16 2024.The manufacturing facilities of the Company are located at Solan Himachal Pradesh and at Bhayla Ahmedabad Gujarat. The Company is engaged in manufacturing trading and marketing of Pharmaceutical products in womens healthcare cardiodiabeto pain management urology and other therapeutic areas. In 2004 Company launched the first division and later named it as Pioneer division in year 2010 launched Xemx multispeciality division in 2005. The production of first manufacturing plant was commissioned at Solan Himachal Pradesh in 2007. The Company launched Gynaecology division in 2008 further launched Cardioloy division in 2013 launched Cardiovascular disease CVD and Solis division in 2016. Later the production at Ahmedabad Plant commissioned in Gujarat in 2021. Radiance and Solaris Divisions launched in 2022 followed by Urology division in 2023. Company is planning an IPO by raising funds of Rs 800 Cr equity shares of Rs 10 each through offer for sale..

Revenue: ₹422.43Cr as on June 2026 (Q1 FY27)
Net Profit: ₹60.11Cr as on June 2026 (Q1 FY27)
Listing date: 15 Dec, 2025
OrganisationCorona Remedies Ltd
HeadquartersAhmedabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Corona Remedies share price today?

Corona Remedies share price today stands at ₹2119.4 as on at the close of the market. Corona Remedies share today touched a day high of ₹2150 and a low of ₹2105.7.

What is the 52 week high and 52 week low range for Corona Remedies share?

Corona Remedies touched a 52 week high of ₹2270.1 and a 52 week low of ₹1336.6. Corona Remedies share price today i.e. is closed at ₹2119.4, which is -6.64% down from its 52 week high and 58.57% up from its 52 week low.

What is Corona Remedies's market capitalisation today?

Corona Remedies market capitalisation is ₹12,923.74 Cr as on .

How to buy Corona Remedies shares?

To buy Corona Remedies shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for CORONA or Corona Remedies Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Corona Remedies shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Corona Remedies trading volume today?

Corona Remedies trading volume is 16.60K as on . This means that 16.60K shares of Corona Remedies were bought and sold on the stock market during today's trading session.